RENTON HOLLINGS — SEC insider filings

SEC reporting owner CIK 1187333. 19 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2021-02-12 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ANAPTYSBIO, INC (ANAB)Director16—10 legs · 61,121 sh · $1,617,13046
Zymeworks Inc. (ZYME)Director2——2
Zymeworks Inc. (ZYME)Director1——1

Insider filings — RENTON HOLLINGS

FiledFormIssuerReported transactionsSource
2026-10-024ANAPTYSBIO, INC (ANAB)Option exercise (M): 5,000 @ $18.03 · Sale (S): 5,000 @ $49.87 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-06-174ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0EDGAR
2026-04-224ANAPTYSBIO, INC (ANAB)Disposition to issuer (D): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · +14 moreEDGAR
2026-01-084ANAPTYSBIO, INC (ANAB)Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2025-08-124ANAPTYSBIO, INC (ANAB)Option exercise (M): 10,231 @ $6.93 · Sale (S): 3,110 @ $19.44 · Sale (S): 7,121 @ $19.70 · Option exercise (M): 10,231 (derivative) @ $0EDGAR
2025-07-034ANAPTYSBIO, INC (ANAB)Option exercise (M): 20,925 @ $6.93 · Sale (S): 7,250 @ $23.09 · Sale (S): 13,675 @ $23.82 · Option exercise (M): 20,925 (derivative) @ $0EDGAR
2025-06-204ANAPTYSBIO, INC (ANAB)Sale (S): 3,015 @ $23.97EDGAR
2025-06-174ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0EDGAR
2025-01-074ANAPTYSBIO, INC (ANAB)Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0EDGAR
2024-12-034ANAPTYSBIO, INC (ANAB)Option exercise (M): 10,000 @ $6.93 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-07-174ANAPTYSBIO, INC (ANAB)Option exercise (M): 10,000 @ $6.93 · Sale (S): 7,103 @ $30.50 · Sale (S): 2,897 @ $30.98 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2024-06-184ANAPTYSBIO, INC (ANAB)Option exercise (M): 3,900 @ $0 · Sale (S): 1,950 @ $23.16 · Option exercise (M): 3,900 (derivative) @ $0EDGAR
2024-01-054ANAPTYSBIO, INC (ANAB)Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0EDGAR
2023-12-084Zymeworks Inc. (ZYME)Grant/award (A): 37,000 (derivative) @ $0EDGAR
2023-01-104ANAPTYSBIO, INC (ANAB)Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 3,900 (derivative) @ $0EDGAR
2022-12-234Zymeworks Inc. (ZYME)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-02-144ANAPTYSBIO, INC (ANAB)Grant/award (A): 9,200 (derivative) @ $0EDGAR
2021-05-074Zymeworks Inc. (ZYME)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2021-02-124ANAPTYSBIO, INC (ANAB)Grant/award (A): 11,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187333 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs